Atria Investments’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$317K Buy
9,847
+2,527
+35% +$89.8K ﹤0.01% 1725
2025
Q4
$264K Buy
7,320
+144
+2% +$5.29K ﹤0.01% 1815
2025
Q3
$226K Sell
7,176
-3,097
-30% -$111K ﹤0.01% 1880
2025
Q2
$437K Buy
10,273
+3,154
+44% +$131K 0.01% 1495
2025
Q1
$318K Sell
7,119
-833
-10% -$44.8K ﹤0.01% 1588
2024
Q4
$437K Buy
7,952
+184
+2% +$9.31K 0.01% 1398
2024
Q3
$328K Buy
7,768
+1,378
+22% +$65.6K ﹤0.01% 1575
2024
Q2
$293K Buy
+6,390
New +$301K ﹤0.01% 1599

Other funds holding VCEL

Atria Investments's VCEL Position: Q1 2026 in Review

Atria Investments increased its Vericel Corp (VCEL) stake by 35% in Q1 2026, buying an estimated $89.8K and bringing the position to 9,847 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #1725.

Atria Investments first reported a position in VCEL in Q2 2024 and has held it in 8 quarters since. The position peaked at $437K in Q2 2025. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Atria Investments held 9,847 shares of Vericel Corp worth $317K as of Q1 2026.
  • Atria Investments bought 2,527 Vericel Corp shares in Q1 2026, an estimated $89.8K.
  • Vericel Corp made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1725 holding.
  • Atria Investments first reported a position in Vericel Corp in Q2 2024 and has held it in 8 quarters since.
  • Atria Investments's Vericel Corp position peaked at $437K in Q2 2025.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.